No Funds for Forced Labor Act

The No Funds for Forced Labor Act (S1685) was introduced in the Senate on May 8, 2025, by Sen. Rick Scott (R-FL) with one cosponsor (Sen. Jeff Merkley, D-OR). It was read twice and referred to the Senate Foreign Relations Committee. There has been no further action. The bill is a procedural directive: it amends the International Financial Institutions Act to require the Treasury Secretary to instruct U.S. Executive Directors at multilateral development banks to oppose loans for projects that use or pose significant risk of using forced labor, specifically citing Xinjiang. Crucially, there is zero direct funding authorization or appropriation—the bill imposes no new taxes, no spending, and no direct penalties on U.S. companies. It operates entirely through U.S. influence at international financial institutions. The money trail is nonexistent in this bill—it is purely a policy directive. The legislative path requires passage by both chambers and presidential signature to become law. Currently, only the Senate version exists with a companion House bill (HR7516) also referred to committee. Both are in the earliest legislative stage. Given the narrow cosponsorship (2 Senators total), no committee hearings or markups have occurred, and no appropriations are tied to implementation, this bill has extremely low near-term probability of enactment. Structural winners and losers: No U.S. companies are directly named or financially impacted by this bill. However, companies with confirmed exposure to Xinjiang supply chains face incremental reputational and regulatory risk under the existing Uyghur Forced Labor Prevention Act (UFLPA). AAPL, AMZN, and TSLA are the most visible large-cap U.S. companies with documented or reasonably inferred exposure: Apple through its supplier base, Amazon through its marketplace, and Tesla through battery and raw material supply. No pure-play companies (e.g., those depending on forced labor as a competitive advantage) are publicly traded in the U.S., so no direct bearish plays exist. Timeline: For this bill to materially affect markets, it would need to pass the Senate Foreign Relations Committee, pass the full Senate, pass the House (via HR7516), and be signed into law—a process that typically takes 12–24 months even for non-controversial measures. Given its partisan and niche nature, combined with the broader geopolitical context (U.S.-China trade relations), the bill is unlikely to advance in this Congress. The only near-term market signal from this bill is as a temperature check on Congressional sentiment toward U.S.-China supply chain decoupling.